Showing 1 - 9 results of 9 for search 'Yngve Falck-Ytter', query time: 0.04s Refine Results
  1. 1
    Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy.

    Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation a... by Elane Reyes-Avilés, Lenche Kostadinova, Anne Rusterholtz, Angelica Cruz-Lebrón, Yngve Falck-Ytter, Donald D Anthony

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease–A population-based study

    Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease–A population-based study by Perica Davitkov, Kyle Hoffman, Yngve Falck-Ytter, Brigid Wilson, Gjorgje Stojadinovikj, Donald D. Anthony, Stanley Martin Cohen, Gregory Cooper

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study.

    Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study. by Perica Davitkov, Kyle Hoffman, Yngve Falck-Ytter, Brigid Wilson, Gjorgje Stojadinovikj, Donald D Anthony, Stanley Martin Cohen, Gregory Cooper

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.

    Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C. by Perica Davitkov, Apoorva Krishna Chandar, Amy Hirsch, Anita Compan, Marina G Silveira, Donald D Anthony, Suzanne Smith, Clare Gideon, Robert A Bonomo, Yngve Falck-Ytter

    Published 2016-01-01
    Get full text
    Article
  5. 5
    Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy

    Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therap... by Lenche Kostadinova, Carey L. Shive, Elizabeth Zebrowski, Brianna Fuller, Kelsey Rife, Amy Hirsch, Anita Compan, Anita Moreland, Yngve Falck-Ytter, Daniel L. Popkin, Donald D. Anthony

    Published 2018-09-01
    Get full text
    Article
  6. 6
    Transient elastography score is elevated during rheumatoid factor-positive chronic hepatitis C virus infection and rheumatoid factor decline is highly variable over the course of direct-acting antiviral therapy.

    Transient elastography score is elevated during rheumatoid factor-positive chronic hepatitis C virus infection and rheumatoid factor decline is highly variable over the course of d... by Ann W N Auma, Corinne Kowal, Carey L Shive, Alyssa Lange, Sofi Damjanovska, Elizabeth Zebrowski, Elane Reyes, Leonard Calabrese, Lenche Kostadinova, Yngve Falck-Ytter, Maya Mattar, Donald D Anthony

    Published 2022-01-01
    Get full text
    Article
  7. 7
    During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study

    During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study by Sofi Damjanovska, Hawwa Alao, Elizabeth Zebrowski, Corinne Kowal, Lenche Kostadinova, Perica Davitkov, Yngve Falck-Ytter, Carey L. Shive, Michael Cartwright, Brian Richardson, David Wald, Mark Cameron, Saba Valadkhan, Donald D. Anthony

    Published 2022-08-01
    Get full text
    Article
  8. 8
    High Red Cell Distribution Width and Low Absolute Lymphocyte Count Associate With Subsequent Mortality in HCV Infection

    High Red Cell Distribution Width and Low Absolute Lymphocyte Count Associate With Subsequent Mortality in HCV Infection by Sofi Damjanovska, Perica Davitkov, Surya Gopal, Lenche Kostadinova, Corrine Kowal, Alyssa Lange, Anita Moreland, Carey Shive, Brigid Wilson, Taissa Bej, Sadeer Al-Kindi, Yngve Falck-Ytter, David Zidar, Donald D. Anthony

    Published 2021-10-01
    Get full text
    Article
  9. 9
    The reporting checklist for public versions of guidelines: RIGHT-PVG

    The reporting checklist for public versions of guidelines: RIGHT-PVG by Xiaoqin Wang, Yaolong Chen, Elie A. Akl, Ružica Tokalić, Ana Marušić, Amir Qaseem, Yngve Falck-Ytter, Myeong Soo Lee, Madelin Siedler, Sarah L. Barber, Mingming Zhang, Edwin S. Y. Chan, Janne Estill, Joey S. W. Kwong, Akiko Okumura, Qi Zhou, Kehu Yang, Susan L. Norris, The RIGHT working group

    Published 2021-01-01
    Get full text
    Article

Search Tools: